Voyager Therapeutics
Utility Patents

Last updated:

List of all Voyager Therapeutics patents 14 in total

Status Patent
Grant
Utility: Treatment of amyotrophic lateral sclerosis (ALS) External link
Filling date: 6 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Compositions for the treatment of disease External link
Filling date: 6 Sep 2025 Issue date: 10 May 2022
Grant
Utility: Methods for biomedical targeting and delivery and devices and systems for practicing the same External link
Filling date: 6 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Compositions for the treatment of disease External link
Filling date: 6 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Modulatory polynucleotides External link
Filling date: 6 Sep 2025 Issue date: 14 Dec 2021
Grant
Utility: Modulatory polynucleotides External link
Filling date: 6 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Closed-ended linear duplex DNA for non-viral gene transfer External link
Filling date: 6 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: AADC polynucleotides for the treatment of Parkinson's disease External link
Filling date: 6 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Assays for the detection of AAV neutralizing antibodies External link
Filling date: 6 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Compositions and methods of treating amyotrophic lateral sclerosis (ALS) External link
Filling date: 6 Sep 2025 Issue date: 16 Feb 2021
Grant
Utility: Compositions and methods of treating amyotrophic lateral sclerosis (ALS) External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2020
Grant
Utility: Modulatory polynucleotides External link
Filling date: 6 Sep 2025 Issue date: 10 Mar 2020
Grant
Utility: Chimeric capsids External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2020
Grant
Utility: Modulatory polynucleotides External link
Filling date: 6 Sep 2025 Issue date: 25 Feb 2020

Showing 1 to 14 of 14 patents.